Manitoba Protection Plan

COVID-19 Research Funding

The Manitoba government is investing more than $5 million in a COVID-19 research fund, administered by Research Manitoba.

Local clinical and scientific researchers and senior officials from the Manitoba government, Shared Health and the Winnipeg Regional Health Authority (WRHA) have identified several new research projects. These include projects to test possible treatments in clinical trials, better understand how the disease is developing in Manitoba and better understand how the health system needs to react to different complications that are emerging around the world.

More than $3.5 million is being used to support clinical and applied research, including $700,000 for Manitoba's first COVID-19 clinical trial for a drug to fight the virus. The study will test whether or not the drug hydroxychloroquine, used to treat rheumatology issues, can prevent people from contracting COVID-19.

An additional $500,000 is being invested in partnerships with industry and philanthropic sources supporting existing trials based in Manitoba but with sites across Canada and in seven other countries around the world. An additional $1 million is being invested in COVID-19 innovation projects, including looking at the development of diagnostic tools.

The development of the fund builds on funding for other research opportunities during the pandemic including:

  • the University of Manitoba investigating how logistical systems can adapt to a pandemic;
  • developing a cost-effective, point-of-need diagnostic test for COVID-19 at the Canadian Science Centre for Human and Animal Health; and
  • developing a COVID-19 vaccine at the University of Manitoba.